Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT04636502
Eligibility Criteria:
Inclusion Criteria:
Participant eligibility is determined according to the following criteria prior to entry into the study:
* The participant or, when applicable, the participant's legally acceptable representative signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.
* Male or female participants with PID, aged less than (\<)18 years treated with SCIG 20% or fSCIG..
* Diagnosis of PID according to the criteria developed by the European Society for Immunodeficiencies (ESID) https://esid.org/About-ESID
* Treatment period for 20% SCIG ranges from November 1, 2017 until June 30, 2020, and for fSCIG from July 1, 2018 until June 30, 2020.
Exclusion Criteria:
* None
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
18 Years
Study:
NCT04636502
Study Brief:
Protocol Section:
NCT04636502